Atropos Health
The partnership combines Atropos Health's expertise in real-world evidence generation with Databricks' data intelligence capabilities.
The collaboration will increase the use cases for healthcare professionals to create care protocols and new treatments in oncology and promote precision medicine.
The partners will leverage real-world evidence and AI, including the ChatRWD platform, to assist with clinical decision-making and medication formulary protocols.
The aim of the partnership is to allow healthcare providers to offer precision medicine support tools.
The alliance will leverage Atropos Health's platform, GENEVA OS, and evidence network for advanced data and analysis.
Brigham Hyde, CEO of Atropos Health, provides the vendor perspective on digital health funding and pitching to venture capitalists in an ever-changing market.
The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.
Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.
The company will use the funds to expand internationally, initially focused on the Japanese and Brazilian markets.
Companies will have access to real-world patient data for clinical decision-making and research support, including hypothesis testing and cohort analysis.